Abu Dhabi, UAE, 24 January 2024: PureLab, a subsidiary of PureHealth, the largest healthcare platform in the Middle East and operator of the largest network of around 150 laboratories in the region, has revealed its new brand identity and strategic vision to advance health outcomes through diagnostic innovations and operational excellence.

The new brand identity was unveiled by PureLab at an exclusive event in Abu Dhabi attended by the region’s healthcare industry leaders, PureHealth representatives, and employees. It reflects PureLab’s commitment to being always dependable, ensuring the patients receive the highest quality healthcare services. The Abu Dhabi-based company’s vision ‘to unlock tomorrow’s healthcare today’ leverages the vital role pathology plays in protecting public health and enhancing patient outcomes.

PureLab offers the largest laboratory test menu for healthcare providers across the region. The company is leveraging innovation and digitalization to support the UAE healthcare ecosystem through precision-driven results that have the power to protect public health and enhance patient care.

Arindam Haldar, Chief Executive Officer, PureLab said, “We are proud to reveal our new brand identity and “Always Dependable” promise to serve partners in their collaborative approach to supporting the UAE’s healthcare ecosystem. We take pride in our role to innovate diagnostic solutions that have the power to transform healthcare practices, develop medical breakthroughs, and ultimately advance patient care.”

“We remain focused on what we can do today so that tomorrow’s healthcare is unlocked and we need to evolve, maintaining our strengths while adding new layers of expertise and reaffirming clinical excellence. Also, We aim to support the UAE’s vision for the highest levels of future health readiness, leveraging speed and accuracy to provide advanced diagnostic solutions. Cutting-edge technology is driving operational excellence within our organisation and our team has an unwavering dedication to innovation, compassionate care, and accessibility,” he continued.

Dr. Farooq Ghani, Chief Medical Officer, PureLab said: “We take immense pride in the launch of PureLab, a testament to our unwavering commitment to advancing healthcare. Together, we are dedicated to elevating health outcomes and bringing innovative solutions to the forefront of healthcare in the UAE. With advanced diagnostics at its core, PureLab has the potential to redefine pathology through cutting-edge technology and personalized health solutions. This is a momentous milestone in our commitment to unlocking a healthier and happier future for all.”

“By combining trust and a superior patient experience, PureLab aims to create an environment where patients can rely on the quality of care they receive. This commitment to excellence is at the core of PureLab’s new mission of “building bridges of trust and setting new pinnacles of precision with credible results and incredible patient care,” he added.

The event served as a platform for internal stakeholders to engage with PureLab’s leadership, fostering a shared understanding of PureLab’s bold vision for the future. The unveiling of the new brand marks the beginning of an exciting chapter for PureLab, as it continues to shape and benefit the UAE’s healthcare ecosystem.

Also Read: Purelab’s PureLIFE Conference 2023: A Historic Event in the Pathology and Laboratory Medicine Sector

PureLab follows international standards for quality management and is accredited through stringent requirements by recognised international bodies such as the College of American Pathologists (CAP), American Association of Blood Banks (AABB), Joint Commission International (JCI), and the International Standards Organization (ISO). Currently, PureLab is the largest network of laboratories accredited by the international leading standards of ISO 15189 across the GCC. PureLab also ensures compliance with local regulators such as the Department of Health in Abu Dhabi (DoH), Dubai Health Authority (DHA), and the UAE Ministry of Health and Prevention (MOHAP).